nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—CYP2C8—Mometasone—atopic dermatitis	0.0789	0.135	CbGbCtD
Irbesartan—PTGS1—Diphenhydramine—atopic dermatitis	0.0785	0.134	CbGbCtD
Irbesartan—CYP2C8—Loratadine—atopic dermatitis	0.0453	0.0775	CbGbCtD
Irbesartan—CYP3A4—Pimecrolimus—atopic dermatitis	0.0422	0.0722	CbGbCtD
Irbesartan—CYP1A2—Diphenhydramine—atopic dermatitis	0.0351	0.06	CbGbCtD
Irbesartan—CYP2C9—Loratadine—atopic dermatitis	0.0316	0.0541	CbGbCtD
Irbesartan—CYP2C9—Diphenhydramine—atopic dermatitis	0.0316	0.0541	CbGbCtD
Irbesartan—CYP2D6—Loratadine—atopic dermatitis	0.0289	0.0495	CbGbCtD
Irbesartan—CYP2D6—Diphenhydramine—atopic dermatitis	0.0289	0.0495	CbGbCtD
Irbesartan—CYP2C8—Hydrocortisone—atopic dermatitis	0.0252	0.0431	CbGbCtD
Irbesartan—CYP3A4—Tacrolimus—atopic dermatitis	0.0251	0.043	CbGbCtD
Irbesartan—CYP3A4—Loratadine—atopic dermatitis	0.0184	0.0314	CbGbCtD
Irbesartan—CYP3A4—Methylprednisolone—atopic dermatitis	0.0168	0.0288	CbGbCtD
Irbesartan—CYP2C8—Dexamethasone—atopic dermatitis	0.0157	0.0268	CbGbCtD
Irbesartan—CYP3A4—Triamcinolone—atopic dermatitis	0.0127	0.0218	CbGbCtD
Irbesartan—CYP2C9—Dexamethasone—atopic dermatitis	0.0109	0.0187	CbGbCtD
Irbesartan—CYP3A4—Betamethasone—atopic dermatitis	0.0109	0.0187	CbGbCtD
Irbesartan—CYP3A4—Prednisolone—atopic dermatitis	0.0108	0.0185	CbGbCtD
Irbesartan—CYP3A4—Hydrocortisone—atopic dermatitis	0.0102	0.0175	CbGbCtD
Irbesartan—CYP3A4—Prednisone—atopic dermatitis	0.0102	0.0174	CbGbCtD
Irbesartan—CYP2D6—Dexamethasone—atopic dermatitis	0.00999	0.0171	CbGbCtD
Irbesartan—CYP3A4—Dexamethasone—atopic dermatitis	0.00636	0.0109	CbGbCtD
Irbesartan—JUN—Betamethasone—Desonide—atopic dermatitis	0.000602	0.0934	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Desonide—atopic dermatitis	0.000602	0.0934	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Fluocinonide—atopic dermatitis	0.000482	0.0748	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Fluocinonide—atopic dermatitis	0.000482	0.0748	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Fluocinolone Acetonide—atopic dermatitis	0.000469	0.0727	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Fluocinolone Acetonide—atopic dermatitis	0.000469	0.0727	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Mometasone—atopic dermatitis	0.000374	0.058	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Mometasone—atopic dermatitis	0.000374	0.058	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Hydrocortisone—atopic dermatitis	0.000237	0.0367	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Hydrocortisone—atopic dermatitis	0.000237	0.0367	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Methylprednisolone—atopic dermatitis	0.000223	0.0346	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Methylprednisolone—atopic dermatitis	0.000223	0.0346	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Betamethasone—atopic dermatitis	0.00022	0.0341	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Dexamethasone—atopic dermatitis	0.00022	0.0341	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Triamcinolone—atopic dermatitis	0.000215	0.0333	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Triamcinolone—atopic dermatitis	0.000215	0.0333	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Prednisone—atopic dermatitis	0.000204	0.0316	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Prednisone—atopic dermatitis	0.000204	0.0316	CbGdCrCtD
Irbesartan—JUN—Dexamethasone—Prednisolone—atopic dermatitis	0.000199	0.0309	CbGdCrCtD
Irbesartan—JUN—Betamethasone—Prednisolone—atopic dermatitis	0.000199	0.0309	CbGdCrCtD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000132	0.000953	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—NFKBIA—atopic dermatitis	0.000132	0.000952	CbGpPWpGaD
Irbesartan—JUN—MyD88-independent cascade—MAPK8—atopic dermatitis	0.000132	0.000951	CbGpPWpGaD
Irbesartan—JUN—Immune System—FCER1A—atopic dermatitis	0.000132	0.00095	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—CXCL10—atopic dermatitis	0.00013	0.000936	CbGpPWpGaD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—MAPK8—atopic dermatitis	0.000129	0.000929	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—CCR5—atopic dermatitis	0.000128	0.000925	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—STAT6—atopic dermatitis	0.000127	0.000919	CbGpPWpGaD
Irbesartan—JUN—ATF-2 transcription factor network—IL6—atopic dermatitis	0.000127	0.000919	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000126	0.00091	CbGpPWpGaD
Irbesartan—JUN—ErbB1 downstream signaling—MAPK8—atopic dermatitis	0.000126	0.000907	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	0.000124	0.000896	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—CASP8—atopic dermatitis	0.000124	0.000896	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CARD11—atopic dermatitis	0.000124	0.000894	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—IFNG—atopic dermatitis	0.000124	0.000892	CbGpPWpGaD
Irbesartan—JUN—Immune System—MS4A2—atopic dermatitis	0.000122	0.000883	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—MAPK8—atopic dermatitis	0.000122	0.000881	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CCL27—atopic dermatitis	0.00012	0.000868	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CCR3—atopic dermatitis	0.00012	0.000866	CbGpPWpGaD
Irbesartan—AGTR1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000119	0.000859	CbGpPWpGaD
Irbesartan—JUN—Apoptosis—TNF—atopic dermatitis	0.000119	0.000858	CbGpPWpGaD
Irbesartan—JUN—Activated TLR4 signalling—MAPK8—atopic dermatitis	0.000119	0.000856	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—NPS—atopic dermatitis	0.000118	0.00085	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—TAC1—atopic dermatitis	0.000118	0.00085	CbGpPWpGaD
Irbesartan—Discomfort—Hydrocortisone—atopic dermatitis	0.000117	0.000431	CcSEcCtD
Irbesartan—Connective tissue disorder—Prednisone—atopic dermatitis	0.000117	0.000431	CcSEcCtD
Irbesartan—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000116	0.000428	CcSEcCtD
Irbesartan—Oedema—Prednisolone—atopic dermatitis	0.000116	0.000428	CcSEcCtD
Irbesartan—AGTR1—Signaling by GPCR—CCL11—atopic dermatitis	0.000116	0.000834	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000116	0.000834	CbGpPWpGaD
Irbesartan—Vomiting—Tacrolimus—atopic dermatitis	0.000115	0.000426	CcSEcCtD
Irbesartan—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000115	0.000424	CcSEcCtD
Irbesartan—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000115	0.000423	CcSEcCtD
Irbesartan—Rash—Tacrolimus—atopic dermatitis	0.000115	0.000423	CcSEcCtD
Irbesartan—Dermatitis—Tacrolimus—atopic dermatitis	0.000114	0.000422	CcSEcCtD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—CXCL8—atopic dermatitis	0.000114	0.000824	CbGpPWpGaD
Irbesartan—Shock—Prednisolone—atopic dermatitis	0.000114	0.000421	CcSEcCtD
Irbesartan—Cough—Triamcinolone—atopic dermatitis	0.000114	0.000421	CcSEcCtD
Irbesartan—AGTR1—Signaling Pathways—FCER2—atopic dermatitis	0.000114	0.000822	CbGpPWpGaD
Irbesartan—Headache—Tacrolimus—atopic dermatitis	0.000114	0.00042	CcSEcCtD
Irbesartan—JUN—Oxidative Stress Induced Senescence—MAPK8—atopic dermatitis	0.000114	0.000821	CbGpPWpGaD
Irbesartan—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000113	0.000418	CcSEcCtD
Irbesartan—Oedema—Hydrocortisone—atopic dermatitis	0.000113	0.000418	CcSEcCtD
Irbesartan—Tachycardia—Prednisolone—atopic dermatitis	0.000113	0.000418	CcSEcCtD
Irbesartan—Hypertension—Triamcinolone—atopic dermatitis	0.000113	0.000417	CcSEcCtD
Irbesartan—Hypertension—Methylprednisolone—atopic dermatitis	0.000113	0.000416	CcSEcCtD
Irbesartan—Infection—Hydrocortisone—atopic dermatitis	0.000113	0.000416	CcSEcCtD
Irbesartan—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000112	0.000414	CcSEcCtD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	0.000112	0.000808	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—CCL5—atopic dermatitis	0.000112	0.000806	CbGpPWpGaD
Irbesartan—JUN—Toll Like Receptor 4 (TLR4) Cascade—MAPK8—atopic dermatitis	0.000111	0.000805	CbGpPWpGaD
Irbesartan—Shock—Hydrocortisone—atopic dermatitis	0.000111	0.000412	CcSEcCtD
Irbesartan—Myalgia—Triamcinolone—atopic dermatitis	0.000111	0.000411	CcSEcCtD
Irbesartan—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000111	0.00041	CcSEcCtD
Irbesartan—JUN—AP-1 transcription factor network—IL6—atopic dermatitis	0.000111	0.000801	CbGpPWpGaD
Irbesartan—Myalgia—Methylprednisolone—atopic dermatitis	0.000111	0.00041	CcSEcCtD
Irbesartan—Arthralgia—Methylprednisolone—atopic dermatitis	0.000111	0.00041	CcSEcCtD
Irbesartan—Anxiety—Methylprednisolone—atopic dermatitis	0.000111	0.000409	CcSEcCtD
Irbesartan—JUN—TNF alpha Signaling Pathway—TNF—atopic dermatitis	0.000111	0.000798	CbGpPWpGaD
Irbesartan—Tachycardia—Hydrocortisone—atopic dermatitis	0.000111	0.000408	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.00011	0.000407	CcSEcCtD
Irbesartan—PTGS1—Selenium Micronutrient Network—IL1B—atopic dermatitis	0.00011	0.000796	CbGpPWpGaD
Irbesartan—Flushing—Prednisone—atopic dermatitis	0.00011	0.000407	CcSEcCtD
Irbesartan—Skin disorder—Hydrocortisone—atopic dermatitis	0.00011	0.000406	CcSEcCtD
Irbesartan—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.00011	0.000406	CcSEcCtD
Irbesartan—Ill-defined disorder—Betamethasone—atopic dermatitis	0.00011	0.000406	CcSEcCtD
Irbesartan—Discomfort—Triamcinolone—atopic dermatitis	0.00011	0.000406	CcSEcCtD
Irbesartan—Discomfort—Methylprednisolone—atopic dermatitis	0.00011	0.000405	CcSEcCtD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—IL1B—atopic dermatitis	0.00011	0.000791	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—IL5—atopic dermatitis	0.00011	0.00079	CbGpPWpGaD
Irbesartan—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.00011	0.000404	CcSEcCtD
Irbesartan—JUN—PDGFR-beta signaling pathway—MAPK8—atopic dermatitis	0.000109	0.000789	CbGpPWpGaD
Irbesartan—JUN—Immune System—DEFB1—atopic dermatitis	0.000109	0.000787	CbGpPWpGaD
Irbesartan—Dry mouth—Triamcinolone—atopic dermatitis	0.000109	0.000402	CcSEcCtD
Irbesartan—Angioedema—Betamethasone—atopic dermatitis	0.000108	0.0004	CcSEcCtD
Irbesartan—Angioedema—Dexamethasone—atopic dermatitis	0.000108	0.0004	CcSEcCtD
Irbesartan—Anorexia—Hydrocortisone—atopic dermatitis	0.000108	0.000399	CcSEcCtD
Irbesartan—EDNRA—Signaling Pathways—CCL17—atopic dermatitis	0.000108	0.000779	CbGpPWpGaD
Irbesartan—Nausea—Tacrolimus—atopic dermatitis	0.000108	0.000398	CcSEcCtD
Irbesartan—Angiopathy—Prednisone—atopic dermatitis	0.000108	0.000398	CcSEcCtD
Irbesartan—Immune system disorder—Prednisone—atopic dermatitis	0.000107	0.000396	CcSEcCtD
Irbesartan—EDNRA—Signaling by GPCR—TAC1—atopic dermatitis	0.000107	0.000772	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—NPS—atopic dermatitis	0.000107	0.000772	CbGpPWpGaD
Irbesartan—Malaise—Betamethasone—atopic dermatitis	0.000107	0.000395	CcSEcCtD
Irbesartan—Malaise—Dexamethasone—atopic dermatitis	0.000107	0.000395	CcSEcCtD
Irbesartan—Oedema—Triamcinolone—atopic dermatitis	0.000107	0.000394	CcSEcCtD
Irbesartan—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000107	0.000394	CcSEcCtD
Irbesartan—Vertigo—Betamethasone—atopic dermatitis	0.000107	0.000393	CcSEcCtD
Irbesartan—Vertigo—Dexamethasone—atopic dermatitis	0.000107	0.000393	CcSEcCtD
Irbesartan—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000106	0.000393	CcSEcCtD
Irbesartan—Syncope—Betamethasone—atopic dermatitis	0.000106	0.000393	CcSEcCtD
Irbesartan—Syncope—Dexamethasone—atopic dermatitis	0.000106	0.000393	CcSEcCtD
Irbesartan—Arrhythmia—Prednisone—atopic dermatitis	0.000106	0.000391	CcSEcCtD
Irbesartan—Infection—Triamcinolone—atopic dermatitis	0.000106	0.000391	CcSEcCtD
Irbesartan—AGTR1—Signaling Pathways—CCL22—atopic dermatitis	0.000106	0.000764	CbGpPWpGaD
Irbesartan—Hypotension—Hydrocortisone—atopic dermatitis	0.000106	0.000391	CcSEcCtD
Irbesartan—Infection—Methylprednisolone—atopic dermatitis	0.000106	0.00039	CcSEcCtD
Irbesartan—JUN—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—atopic dermatitis	0.000105	0.000758	CbGpPWpGaD
Irbesartan—Shock—Triamcinolone—atopic dermatitis	0.000105	0.000388	CcSEcCtD
Irbesartan—EDNRA—Signaling by GPCR—CXCR3—atopic dermatitis	0.000105	0.000757	CbGpPWpGaD
Irbesartan—Shock—Methylprednisolone—atopic dermatitis	0.000105	0.000387	CcSEcCtD
Irbesartan—JUN—TGF-beta Signaling Pathway—MAPK8—atopic dermatitis	0.000105	0.000756	CbGpPWpGaD
Irbesartan—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000104	0.000385	CcSEcCtD
Irbesartan—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000104	0.000385	CcSEcCtD
Irbesartan—Loss of consciousness—Betamethasone—atopic dermatitis	0.000104	0.000385	CcSEcCtD
Irbesartan—Paraesthesia—Prednisolone—atopic dermatitis	0.000104	0.000385	CcSEcCtD
Irbesartan—JUN—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	0.000104	0.000751	CbGpPWpGaD
Irbesartan—Tachycardia—Triamcinolone—atopic dermatitis	0.000104	0.000384	CcSEcCtD
Irbesartan—Tachycardia—Methylprednisolone—atopic dermatitis	0.000104	0.000384	CcSEcCtD
Irbesartan—AGTR1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000104	0.000749	CbGpPWpGaD
Irbesartan—Skin disorder—Methylprednisolone—atopic dermatitis	0.000103	0.000382	CcSEcCtD
Irbesartan—Erythema—Prednisone—atopic dermatitis	0.000103	0.000381	CcSEcCtD
Irbesartan—Malnutrition—Prednisone—atopic dermatitis	0.000103	0.000381	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000103	0.000381	CcSEcCtD
Irbesartan—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000103	0.000381	CcSEcCtD
Irbesartan—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000103	0.00038	CcSEcCtD
Irbesartan—Hypertension—Dexamethasone—atopic dermatitis	0.000102	0.000378	CcSEcCtD
Irbesartan—Hypertension—Betamethasone—atopic dermatitis	0.000102	0.000378	CcSEcCtD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—TNF—atopic dermatitis	0.000102	0.000735	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000102	0.000734	CbGpPWpGaD
Irbesartan—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000102	0.000376	CcSEcCtD
Irbesartan—Myalgia—Dexamethasone—atopic dermatitis	0.000101	0.000373	CcSEcCtD
Irbesartan—Myalgia—Betamethasone—atopic dermatitis	0.000101	0.000373	CcSEcCtD
Irbesartan—Anxiety—Betamethasone—atopic dermatitis	0.000101	0.000372	CcSEcCtD
Irbesartan—Anxiety—Dexamethasone—atopic dermatitis	0.000101	0.000372	CcSEcCtD
Irbesartan—AGTR1—GPCR ligand binding—CCR5—atopic dermatitis	0.000101	0.000726	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—MAPK8—atopic dermatitis	0.0001	0.000725	CbGpPWpGaD
Irbesartan—JUN—Myometrial Relaxation and Contraction Pathways—IL1B—atopic dermatitis	0.0001	0.000725	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	9.99e-05	0.000721	CbGpPWpGaD
Irbesartan—Discomfort—Dexamethasone—atopic dermatitis	9.98e-05	0.000368	CcSEcCtD
Irbesartan—Discomfort—Betamethasone—atopic dermatitis	9.98e-05	0.000368	CcSEcCtD
Irbesartan—UGT1A3—Metabolism—GLB1—atopic dermatitis	9.97e-05	0.00072	CbGpPWpGaD
Irbesartan—Dyspepsia—Hydrocortisone—atopic dermatitis	9.97e-05	0.000368	CcSEcCtD
Irbesartan—EDNRA—Signaling by GPCR—IL5—atopic dermatitis	9.95e-05	0.000718	CbGpPWpGaD
Irbesartan—Hypotension—Methylprednisolone—atopic dermatitis	9.95e-05	0.000367	CcSEcCtD
Irbesartan—JUN—Toll-Like Receptors Cascades—MAPK8—atopic dermatitis	9.93e-05	0.000717	CbGpPWpGaD
Irbesartan—Pain—Prednisolone—atopic dermatitis	9.92e-05	0.000366	CcSEcCtD
Irbesartan—Decreased appetite—Hydrocortisone—atopic dermatitis	9.85e-05	0.000364	CcSEcCtD
Irbesartan—JUN—Glucocorticoid receptor regulatory network—IL6—atopic dermatitis	9.78e-05	0.000706	CbGpPWpGaD
Irbesartan—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	9.78e-05	0.000361	CcSEcCtD
Irbesartan—Fatigue—Hydrocortisone—atopic dermatitis	9.77e-05	0.000361	CcSEcCtD
Irbesartan—JUN—BDNF signaling pathway—MAPK8—atopic dermatitis	9.76e-05	0.000705	CbGpPWpGaD
Irbesartan—Vision blurred—Prednisone—atopic dermatitis	9.73e-05	0.000359	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	9.72e-05	0.000359	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	9.7e-05	0.000358	CcSEcCtD
Irbesartan—Pain—Hydrocortisone—atopic dermatitis	9.69e-05	0.000358	CcSEcCtD
Irbesartan—Anaphylactic shock—Betamethasone—atopic dermatitis	9.68e-05	0.000357	CcSEcCtD
Irbesartan—Anaphylactic shock—Dexamethasone—atopic dermatitis	9.68e-05	0.000357	CcSEcCtD
Irbesartan—Oedema—Dexamethasone—atopic dermatitis	9.68e-05	0.000357	CcSEcCtD
Irbesartan—Oedema—Betamethasone—atopic dermatitis	9.68e-05	0.000357	CcSEcCtD
Irbesartan—JUN—Innate Immune System—CASP1—atopic dermatitis	9.65e-05	0.000696	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—KIF3A—atopic dermatitis	9.62e-05	0.000694	CbGpPWpGaD
Irbesartan—Infection—Dexamethasone—atopic dermatitis	9.62e-05	0.000355	CcSEcCtD
Irbesartan—Infection—Betamethasone—atopic dermatitis	9.62e-05	0.000355	CcSEcCtD
Irbesartan—Ill-defined disorder—Prednisone—atopic dermatitis	9.58e-05	0.000354	CcSEcCtD
Irbesartan—Paraesthesia—Triamcinolone—atopic dermatitis	9.58e-05	0.000354	CcSEcCtD
Irbesartan—UGT1A3—Metabolism—ADSL—atopic dermatitis	9.56e-05	0.00069	CbGpPWpGaD
Irbesartan—Feeling abnormal—Prednisolone—atopic dermatitis	9.56e-05	0.000353	CcSEcCtD
Irbesartan—Paraesthesia—Methylprednisolone—atopic dermatitis	9.56e-05	0.000353	CcSEcCtD
Irbesartan—Anaemia—Prednisone—atopic dermatitis	9.55e-05	0.000353	CcSEcCtD
Irbesartan—Shock—Betamethasone—atopic dermatitis	9.52e-05	0.000352	CcSEcCtD
Irbesartan—Shock—Dexamethasone—atopic dermatitis	9.52e-05	0.000352	CcSEcCtD
Irbesartan—Dyspnoea—Triamcinolone—atopic dermatitis	9.51e-05	0.000351	CcSEcCtD
Irbesartan—JUN—MyD88 cascade initiated on plasma membrane—IL6—atopic dermatitis	9.51e-05	0.000686	CbGpPWpGaD
Irbesartan—Nervous system disorder—Betamethasone—atopic dermatitis	9.49e-05	0.000351	CcSEcCtD
Irbesartan—Nervous system disorder—Dexamethasone—atopic dermatitis	9.49e-05	0.000351	CcSEcCtD
Irbesartan—Agitation—Prednisone—atopic dermatitis	9.49e-05	0.000351	CcSEcCtD
Irbesartan—Thrombocytopenia—Dexamethasone—atopic dermatitis	9.48e-05	0.00035	CcSEcCtD
Irbesartan—Thrombocytopenia—Betamethasone—atopic dermatitis	9.48e-05	0.00035	CcSEcCtD
Irbesartan—Tachycardia—Dexamethasone—atopic dermatitis	9.45e-05	0.000349	CcSEcCtD
Irbesartan—Tachycardia—Betamethasone—atopic dermatitis	9.45e-05	0.000349	CcSEcCtD
Irbesartan—AGTR1—Signaling Pathways—CCL27—atopic dermatitis	9.44e-05	0.000681	CbGpPWpGaD
Irbesartan—Angioedema—Prednisone—atopic dermatitis	9.44e-05	0.000349	CcSEcCtD
Irbesartan—AGTR1—Signaling by GPCR—CCR3—atopic dermatitis	9.42e-05	0.00068	CbGpPWpGaD
Irbesartan—JUN—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—atopic dermatitis	9.42e-05	0.00068	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—IL1B—atopic dermatitis	9.41e-05	0.000679	CbGpPWpGaD
Irbesartan—Dyspepsia—Triamcinolone—atopic dermatitis	9.39e-05	0.000347	CcSEcCtD
Irbesartan—Dyspepsia—Methylprednisolone—atopic dermatitis	9.37e-05	0.000346	CcSEcCtD
Irbesartan—Hyperhidrosis—Dexamethasone—atopic dermatitis	9.36e-05	0.000346	CcSEcCtD
Irbesartan—Hyperhidrosis—Betamethasone—atopic dermatitis	9.36e-05	0.000346	CcSEcCtD
Irbesartan—EDNRA—GPCR downstream signaling—CXCL10—atopic dermatitis	9.34e-05	0.000674	CbGpPWpGaD
Irbesartan—Feeling abnormal—Hydrocortisone—atopic dermatitis	9.34e-05	0.000345	CcSEcCtD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	9.33e-05	0.000673	CbGpPWpGaD
Irbesartan—Malaise—Prednisone—atopic dermatitis	9.31e-05	0.000344	CcSEcCtD
Irbesartan—Vertigo—Prednisone—atopic dermatitis	9.28e-05	0.000343	CcSEcCtD
Irbesartan—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	9.26e-05	0.000342	CcSEcCtD
Irbesartan—Syncope—Prednisone—atopic dermatitis	9.26e-05	0.000342	CcSEcCtD
Irbesartan—JUN—MyD88 dependent cascade initiated on endosome—IL6—atopic dermatitis	9.25e-05	0.000667	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—NPS—atopic dermatitis	9.24e-05	0.000667	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—TAC1—atopic dermatitis	9.24e-05	0.000667	CbGpPWpGaD
Irbesartan—Anorexia—Betamethasone—atopic dermatitis	9.23e-05	0.000341	CcSEcCtD
Irbesartan—Anorexia—Dexamethasone—atopic dermatitis	9.23e-05	0.000341	CcSEcCtD
Irbesartan—Urticaria—Prednisolone—atopic dermatitis	9.21e-05	0.00034	CcSEcCtD
Irbesartan—Fatigue—Triamcinolone—atopic dermatitis	9.2e-05	0.00034	CcSEcCtD
Irbesartan—Fatigue—Methylprednisolone—atopic dermatitis	9.18e-05	0.000339	CcSEcCtD
Irbesartan—Pain—Triamcinolone—atopic dermatitis	9.12e-05	0.000337	CcSEcCtD
Irbesartan—JUN—TCR Signaling Pathway—IL6—atopic dermatitis	9.08e-05	0.000655	CbGpPWpGaD
Irbesartan—Loss of consciousness—Prednisone—atopic dermatitis	9.08e-05	0.000335	CcSEcCtD
Irbesartan—AGTR1—GPCR downstream signaling—CXCR3—atopic dermatitis	9.07e-05	0.000654	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—CXCL8—atopic dermatitis	9.05e-05	0.000653	CbGpPWpGaD
Irbesartan—Hypotension—Dexamethasone—atopic dermatitis	9.04e-05	0.000334	CcSEcCtD
Irbesartan—Hypotension—Betamethasone—atopic dermatitis	9.04e-05	0.000334	CcSEcCtD
Irbesartan—Urticaria—Hydrocortisone—atopic dermatitis	9e-05	0.000332	CcSEcCtD
Irbesartan—JUN—Insulin Signaling—MAPK8—atopic dermatitis	8.98e-05	0.000648	CbGpPWpGaD
Irbesartan—Abdominal pain—Hydrocortisone—atopic dermatitis	8.96e-05	0.000331	CcSEcCtD
Irbesartan—Body temperature increased—Hydrocortisone—atopic dermatitis	8.96e-05	0.000331	CcSEcCtD
Irbesartan—JUN—TNF alpha Signaling Pathway—IL6—atopic dermatitis	8.92e-05	0.000644	CbGpPWpGaD
Irbesartan—JUN—Toll Like Receptor 9 (TLR9) Cascade—IL6—atopic dermatitis	8.92e-05	0.000644	CbGpPWpGaD
Irbesartan—Hypertension—Prednisone—atopic dermatitis	8.92e-05	0.000329	CcSEcCtD
Irbesartan—JUN—EGF/EGFR Signaling Pathway—MAPK8—atopic dermatitis	8.89e-05	0.000641	CbGpPWpGaD
Irbesartan—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	8.82e-05	0.000326	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	8.82e-05	0.000326	CcSEcCtD
Irbesartan—Arthralgia—Prednisone—atopic dermatitis	8.79e-05	0.000325	CcSEcCtD
Irbesartan—Myalgia—Prednisone—atopic dermatitis	8.79e-05	0.000325	CcSEcCtD
Irbesartan—Feeling abnormal—Triamcinolone—atopic dermatitis	8.79e-05	0.000325	CcSEcCtD
Irbesartan—JUN—MyD88:Mal cascade initiated on plasma membrane—IL6—atopic dermatitis	8.77e-05	0.000633	CbGpPWpGaD
Irbesartan—Feeling abnormal—Methylprednisolone—atopic dermatitis	8.77e-05	0.000324	CcSEcCtD
Irbesartan—Anxiety—Prednisone—atopic dermatitis	8.76e-05	0.000324	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	8.73e-05	0.000322	CcSEcCtD
Irbesartan—JUN—Innate Immune System—TLR2—atopic dermatitis	8.73e-05	0.00063	CbGpPWpGaD
Irbesartan—JUN—Immune System—KIF3A—atopic dermatitis	8.72e-05	0.000629	CbGpPWpGaD
Irbesartan—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	8.7e-05	0.000321	CcSEcCtD
Irbesartan—EDNRA—Signaling Pathways—CMA1—atopic dermatitis	8.7e-05	0.000628	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CCL11—atopic dermatitis	8.7e-05	0.000628	CbGpPWpGaD
Irbesartan—Paraesthesia—Betamethasone—atopic dermatitis	8.69e-05	0.000321	CcSEcCtD
Irbesartan—Paraesthesia—Dexamethasone—atopic dermatitis	8.69e-05	0.000321	CcSEcCtD
Irbesartan—Discomfort—Prednisone—atopic dermatitis	8.69e-05	0.000321	CcSEcCtD
Irbesartan—JUN—MAPK Signaling Pathway—MAPK8—atopic dermatitis	8.63e-05	0.000623	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—IL5—atopic dermatitis	8.59e-05	0.00062	CbGpPWpGaD
Irbesartan—Hypersensitivity—Prednisolone—atopic dermatitis	8.55e-05	0.000316	CcSEcCtD
Irbesartan—Dyspepsia—Dexamethasone—atopic dermatitis	8.52e-05	0.000315	CcSEcCtD
Irbesartan—Dyspepsia—Betamethasone—atopic dermatitis	8.52e-05	0.000315	CcSEcCtD
Irbesartan—JUN—Signaling Pathways—FCER2—atopic dermatitis	8.51e-05	0.000614	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CXCL10—atopic dermatitis	8.48e-05	0.000612	CbGpPWpGaD
Irbesartan—Urticaria—Triamcinolone—atopic dermatitis	8.47e-05	0.000313	CcSEcCtD
Irbesartan—AGTR1—Signaling Pathways—CCL17—atopic dermatitis	8.47e-05	0.000611	CbGpPWpGaD
Irbesartan—Urticaria—Methylprednisolone—atopic dermatitis	8.46e-05	0.000312	CcSEcCtD
Irbesartan—Body temperature increased—Triamcinolone—atopic dermatitis	8.43e-05	0.000311	CcSEcCtD
Irbesartan—Oedema—Prednisone—atopic dermatitis	8.43e-05	0.000311	CcSEcCtD
Irbesartan—Anaphylactic shock—Prednisone—atopic dermatitis	8.43e-05	0.000311	CcSEcCtD
Irbesartan—JUN—MyD88-independent cascade—IL6—atopic dermatitis	8.42e-05	0.000607	CbGpPWpGaD
Irbesartan—Abdominal pain—Methylprednisolone—atopic dermatitis	8.41e-05	0.000311	CcSEcCtD
Irbesartan—Decreased appetite—Dexamethasone—atopic dermatitis	8.41e-05	0.000311	CcSEcCtD
Irbesartan—Decreased appetite—Betamethasone—atopic dermatitis	8.41e-05	0.000311	CcSEcCtD
Irbesartan—AGTR1—Signaling by GPCR—NPS—atopic dermatitis	8.39e-05	0.000606	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—TAC1—atopic dermatitis	8.39e-05	0.000606	CbGpPWpGaD
Irbesartan—Infection—Prednisone—atopic dermatitis	8.37e-05	0.000309	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	8.36e-05	0.000309	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Betamethasone—atopic dermatitis	8.36e-05	0.000309	CcSEcCtD
Irbesartan—Hypersensitivity—Hydrocortisone—atopic dermatitis	8.35e-05	0.000308	CcSEcCtD
Irbesartan—Fatigue—Dexamethasone—atopic dermatitis	8.34e-05	0.000308	CcSEcCtD
Irbesartan—Fatigue—Betamethasone—atopic dermatitis	8.34e-05	0.000308	CcSEcCtD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	8.32e-05	0.000601	CbGpPWpGaD
Irbesartan—Shock—Prednisone—atopic dermatitis	8.29e-05	0.000306	CcSEcCtD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	8.29e-05	0.000598	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—MAPK8—atopic dermatitis	8.28e-05	0.000598	CbGpPWpGaD
Irbesartan—Pain—Betamethasone—atopic dermatitis	8.28e-05	0.000306	CcSEcCtD
Irbesartan—Pain—Dexamethasone—atopic dermatitis	8.28e-05	0.000306	CcSEcCtD
Irbesartan—Nervous system disorder—Prednisone—atopic dermatitis	8.27e-05	0.000305	CcSEcCtD
Irbesartan—AGTR1—Signaling by GPCR—CXCR3—atopic dermatitis	8.23e-05	0.000594	CbGpPWpGaD
Irbesartan—Tachycardia—Prednisone—atopic dermatitis	8.23e-05	0.000304	CcSEcCtD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—IL6—atopic dermatitis	8.22e-05	0.000593	CbGpPWpGaD
Irbesartan—Skin disorder—Prednisone—atopic dermatitis	8.19e-05	0.000302	CcSEcCtD
Irbesartan—EDNRA—Signaling Pathways—STAT6—atopic dermatitis	8.18e-05	0.00059	CbGpPWpGaD
Irbesartan—Hyperhidrosis—Prednisone—atopic dermatitis	8.15e-05	0.000301	CcSEcCtD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	8.15e-05	0.000588	CbGpPWpGaD
Irbesartan—Asthenia—Hydrocortisone—atopic dermatitis	8.13e-05	0.0003	CcSEcCtD
Irbesartan—EDNRA—GPCR downstream signaling—CCL5—atopic dermatitis	8.04e-05	0.00058	CbGpPWpGaD
Irbesartan—Anorexia—Prednisone—atopic dermatitis	8.03e-05	0.000297	CcSEcCtD
Irbesartan—JUN—Senescence and Autophagy in Cancer—IL6—atopic dermatitis	8.03e-05	0.000579	CbGpPWpGaD
Irbesartan—JUN—Senescence-Associated Secretory Phenotype (SASP)—IL6—atopic dermatitis	8.03e-05	0.000579	CbGpPWpGaD
Irbesartan—Pruritus—Hydrocortisone—atopic dermatitis	8.01e-05	0.000296	CcSEcCtD
Irbesartan—PTGS1—Selenium Micronutrient Network—TNF—atopic dermatitis	8e-05	0.000577	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	7.98e-05	0.000576	CbGpPWpGaD
Irbesartan—Feeling abnormal—Betamethasone—atopic dermatitis	7.98e-05	0.000295	CcSEcCtD
Irbesartan—Feeling abnormal—Dexamethasone—atopic dermatitis	7.98e-05	0.000295	CcSEcCtD
Irbesartan—JUN—Cellular Senescence—MAPK8—atopic dermatitis	7.96e-05	0.000574	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—TNF—atopic dermatitis	7.95e-05	0.000574	CbGpPWpGaD
Irbesartan—Gastrointestinal pain—Betamethasone—atopic dermatitis	7.91e-05	0.000292	CcSEcCtD
Irbesartan—Gastrointestinal pain—Dexamethasone—atopic dermatitis	7.91e-05	0.000292	CcSEcCtD
Irbesartan—JUN—Signaling Pathways—CCL22—atopic dermatitis	7.91e-05	0.000571	CbGpPWpGaD
Irbesartan—Hypersensitivity—Triamcinolone—atopic dermatitis	7.86e-05	0.00029	CcSEcCtD
Irbesartan—Hypersensitivity—Methylprednisolone—atopic dermatitis	7.84e-05	0.00029	CcSEcCtD
Irbesartan—JUN—Focal Adhesion—MAPK8—atopic dermatitis	7.82e-05	0.000565	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL5—atopic dermatitis	7.8e-05	0.000563	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	7.79e-05	0.000562	CbGpPWpGaD
Irbesartan—Diarrhoea—Hydrocortisone—atopic dermatitis	7.75e-05	0.000286	CcSEcCtD
Irbesartan—EDNRA—GPCR ligand binding—CXCL8—atopic dermatitis	7.75e-05	0.000559	CbGpPWpGaD
Irbesartan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	7.72e-05	0.000557	CbGpPWpGaD
Irbesartan—Urticaria—Dexamethasone—atopic dermatitis	7.69e-05	0.000284	CcSEcCtD
Irbesartan—Urticaria—Betamethasone—atopic dermatitis	7.69e-05	0.000284	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Prednisone—atopic dermatitis	7.68e-05	0.000284	CcSEcCtD
Irbesartan—Dizziness—Prednisolone—atopic dermatitis	7.67e-05	0.000283	CcSEcCtD
Irbesartan—Asthenia—Triamcinolone—atopic dermatitis	7.65e-05	0.000283	CcSEcCtD
Irbesartan—Abdominal pain—Dexamethasone—atopic dermatitis	7.65e-05	0.000283	CcSEcCtD
Irbesartan—Abdominal pain—Betamethasone—atopic dermatitis	7.65e-05	0.000283	CcSEcCtD
Irbesartan—Body temperature increased—Betamethasone—atopic dermatitis	7.65e-05	0.000283	CcSEcCtD
Irbesartan—Body temperature increased—Dexamethasone—atopic dermatitis	7.65e-05	0.000283	CcSEcCtD
Irbesartan—Asthenia—Methylprednisolone—atopic dermatitis	7.64e-05	0.000282	CcSEcCtD
Irbesartan—JUN—Activated TLR4 signalling—IL6—atopic dermatitis	7.57e-05	0.000546	CbGpPWpGaD
Irbesartan—Paraesthesia—Prednisone—atopic dermatitis	7.57e-05	0.00028	CcSEcCtD
Irbesartan—AGTR1—Signaling Pathways—KIF3A—atopic dermatitis	7.55e-05	0.000545	CbGpPWpGaD
Irbesartan—Pruritus—Triamcinolone—atopic dermatitis	7.55e-05	0.000279	CcSEcCtD
Irbesartan—Pruritus—Methylprednisolone—atopic dermatitis	7.53e-05	0.000278	CcSEcCtD
Irbesartan—Dizziness—Hydrocortisone—atopic dermatitis	7.49e-05	0.000277	CcSEcCtD
Irbesartan—JUN—Circadian rythm related genes—MAPK8—atopic dermatitis	7.48e-05	0.00054	CbGpPWpGaD
Irbesartan—Dyspepsia—Prednisone—atopic dermatitis	7.42e-05	0.000274	CcSEcCtD
Irbesartan—JUN—Immune System—STAT6—atopic dermatitis	7.42e-05	0.000535	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CXCL10—atopic dermatitis	7.33e-05	0.000529	CbGpPWpGaD
Irbesartan—Decreased appetite—Prednisone—atopic dermatitis	7.33e-05	0.000271	CcSEcCtD
Irbesartan—Rash—Prednisolone—atopic dermatitis	7.31e-05	0.00027	CcSEcCtD
Irbesartan—Dermatitis—Prednisolone—atopic dermatitis	7.31e-05	0.00027	CcSEcCtD
Irbesartan—EDNRA—Signaling by GPCR—CCL5—atopic dermatitis	7.3e-05	0.000527	CbGpPWpGaD
Irbesartan—Diarrhoea—Methylprednisolone—atopic dermatitis	7.28e-05	0.000269	CcSEcCtD
Irbesartan—Fatigue—Prednisone—atopic dermatitis	7.27e-05	0.000268	CcSEcCtD
Irbesartan—Headache—Prednisolone—atopic dermatitis	7.27e-05	0.000268	CcSEcCtD
Irbesartan—JUN—SIDS Susceptibility Pathways—TNF—atopic dermatitis	7.25e-05	0.000523	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—CCR5—atopic dermatitis	7.24e-05	0.000523	CbGpPWpGaD
Irbesartan—JUN—Immune System—CARD11—atopic dermatitis	7.21e-05	0.000521	CbGpPWpGaD
Irbesartan—Constipation—Prednisone—atopic dermatitis	7.21e-05	0.000266	CcSEcCtD
Irbesartan—Vomiting—Hydrocortisone—atopic dermatitis	7.2e-05	0.000266	CcSEcCtD
Irbesartan—Rash—Hydrocortisone—atopic dermatitis	7.14e-05	0.000264	CcSEcCtD
Irbesartan—Dermatitis—Hydrocortisone—atopic dermatitis	7.14e-05	0.000264	CcSEcCtD
Irbesartan—JUN—Toll Like Receptor 4 (TLR4) Cascade—IL6—atopic dermatitis	7.12e-05	0.000514	CbGpPWpGaD
Irbesartan—Headache—Hydrocortisone—atopic dermatitis	7.1e-05	0.000262	CcSEcCtD
Irbesartan—EDNRA—Signaling Pathways—CCR3—atopic dermatitis	7.09e-05	0.000512	CbGpPWpGaD
Irbesartan—Dizziness—Triamcinolone—atopic dermatitis	7.05e-05	0.000261	CcSEcCtD
Irbesartan—JUN—Signaling Pathways—CCL27—atopic dermatitis	7.05e-05	0.000509	CbGpPWpGaD
Irbesartan—Dizziness—Methylprednisolone—atopic dermatitis	7.04e-05	0.00026	CcSEcCtD
Irbesartan—Feeling abnormal—Prednisone—atopic dermatitis	6.95e-05	0.000257	CcSEcCtD
Irbesartan—Asthenia—Betamethasone—atopic dermatitis	6.94e-05	0.000256	CcSEcCtD
Irbesartan—Asthenia—Dexamethasone—atopic dermatitis	6.94e-05	0.000256	CcSEcCtD
Irbesartan—Gastrointestinal pain—Prednisone—atopic dermatitis	6.89e-05	0.000255	CcSEcCtD
Irbesartan—Nausea—Prednisolone—atopic dermatitis	6.89e-05	0.000254	CcSEcCtD
Irbesartan—Pruritus—Betamethasone—atopic dermatitis	6.85e-05	0.000253	CcSEcCtD
Irbesartan—Pruritus—Dexamethasone—atopic dermatitis	6.85e-05	0.000253	CcSEcCtD
Irbesartan—JUN—Cellular responses to stress—CXCL8—atopic dermatitis	6.84e-05	0.000493	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—TNF—atopic dermatitis	6.83e-05	0.000493	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CMA1—atopic dermatitis	6.83e-05	0.000493	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CCL11—atopic dermatitis	6.83e-05	0.000493	CbGpPWpGaD
Irbesartan—Vomiting—Triamcinolone—atopic dermatitis	6.78e-05	0.00025	CcSEcCtD
Irbesartan—Vomiting—Methylprednisolone—atopic dermatitis	6.77e-05	0.00025	CcSEcCtD
Irbesartan—Nausea—Hydrocortisone—atopic dermatitis	6.73e-05	0.000249	CcSEcCtD
Irbesartan—Rash—Triamcinolone—atopic dermatitis	6.73e-05	0.000248	CcSEcCtD
Irbesartan—Dermatitis—Triamcinolone—atopic dermatitis	6.72e-05	0.000248	CcSEcCtD
Irbesartan—Rash—Methylprednisolone—atopic dermatitis	6.71e-05	0.000248	CcSEcCtD
Irbesartan—Dermatitis—Methylprednisolone—atopic dermatitis	6.7e-05	0.000248	CcSEcCtD
Irbesartan—Urticaria—Prednisone—atopic dermatitis	6.7e-05	0.000247	CcSEcCtD
Irbesartan—Headache—Triamcinolone—atopic dermatitis	6.68e-05	0.000247	CcSEcCtD
Irbesartan—Headache—Methylprednisolone—atopic dermatitis	6.67e-05	0.000246	CcSEcCtD
Irbesartan—Body temperature increased—Prednisone—atopic dermatitis	6.66e-05	0.000246	CcSEcCtD
Irbesartan—Abdominal pain—Prednisone—atopic dermatitis	6.66e-05	0.000246	CcSEcCtD
Irbesartan—AGTR1—Signaling by GPCR—CXCL10—atopic dermatitis	6.65e-05	0.00048	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	6.63e-05	0.000479	CbGpPWpGaD
Irbesartan—Diarrhoea—Dexamethasone—atopic dermatitis	6.62e-05	0.000245	CcSEcCtD
Irbesartan—Diarrhoea—Betamethasone—atopic dermatitis	6.62e-05	0.000245	CcSEcCtD
Irbesartan—EDNRA—Signaling by GPCR—CCR5—atopic dermatitis	6.58e-05	0.000475	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—IL6—atopic dermatitis	6.45e-05	0.000466	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—STAT6—atopic dermatitis	6.42e-05	0.000463	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—IL6—atopic dermatitis	6.41e-05	0.000463	CbGpPWpGaD
Irbesartan—Dizziness—Dexamethasone—atopic dermatitis	6.4e-05	0.000236	CcSEcCtD
Irbesartan—Dizziness—Betamethasone—atopic dermatitis	6.4e-05	0.000236	CcSEcCtD
Irbesartan—JUN—Toll-Like Receptors Cascades—IL6—atopic dermatitis	6.34e-05	0.000458	CbGpPWpGaD
Irbesartan—Nausea—Triamcinolone—atopic dermatitis	6.34e-05	0.000234	CcSEcCtD
Irbesartan—JUN—Signaling Pathways—CCL17—atopic dermatitis	6.33e-05	0.000457	CbGpPWpGaD
Irbesartan—Nausea—Methylprednisolone—atopic dermatitis	6.32e-05	0.000233	CcSEcCtD
Irbesartan—EDNRA—Signaling Pathways—TAC1—atopic dermatitis	6.32e-05	0.000456	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—NPS—atopic dermatitis	6.32e-05	0.000456	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CCL5—atopic dermatitis	6.31e-05	0.000455	CbGpPWpGaD
Irbesartan—Hypersensitivity—Prednisone—atopic dermatitis	6.21e-05	0.000229	CcSEcCtD
Irbesartan—EDNRA—Signaling Pathways—CXCR3—atopic dermatitis	6.2e-05	0.000447	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	6.16e-05	0.000445	CbGpPWpGaD
Irbesartan—Vomiting—Betamethasone—atopic dermatitis	6.15e-05	0.000227	CcSEcCtD
Irbesartan—Vomiting—Dexamethasone—atopic dermatitis	6.15e-05	0.000227	CcSEcCtD
Irbesartan—Rash—Betamethasone—atopic dermatitis	6.1e-05	0.000225	CcSEcCtD
Irbesartan—Rash—Dexamethasone—atopic dermatitis	6.1e-05	0.000225	CcSEcCtD
Irbesartan—Dermatitis—Betamethasone—atopic dermatitis	6.1e-05	0.000225	CcSEcCtD
Irbesartan—Dermatitis—Dexamethasone—atopic dermatitis	6.1e-05	0.000225	CcSEcCtD
Irbesartan—AGTR1—GPCR ligand binding—CXCL8—atopic dermatitis	6.08e-05	0.000439	CbGpPWpGaD
Irbesartan—Headache—Betamethasone—atopic dermatitis	6.06e-05	0.000224	CcSEcCtD
Irbesartan—Headache—Dexamethasone—atopic dermatitis	6.06e-05	0.000224	CcSEcCtD
Irbesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	6.06e-05	0.000437	CbGpPWpGaD
Irbesartan—Asthenia—Prednisone—atopic dermatitis	6.05e-05	0.000223	CcSEcCtD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	6.04e-05	0.000436	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	6.04e-05	0.000436	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—MAPK8—atopic dermatitis	6.01e-05	0.000434	CbGpPWpGaD
Irbesartan—Pruritus—Prednisone—atopic dermatitis	5.96e-05	0.00022	CcSEcCtD
Irbesartan—JUN—Myometrial Relaxation and Contraction Pathways—IL6—atopic dermatitis	5.88e-05	0.000424	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL5—atopic dermatitis	5.88e-05	0.000424	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—IL6—atopic dermatitis	5.85e-05	0.000422	CbGpPWpGaD
Irbesartan—Diarrhoea—Prednisone—atopic dermatitis	5.77e-05	0.000213	CcSEcCtD
Irbesartan—Nausea—Betamethasone—atopic dermatitis	5.75e-05	0.000212	CcSEcCtD
Irbesartan—Nausea—Dexamethasone—atopic dermatitis	5.75e-05	0.000212	CcSEcCtD
Irbesartan—AGTR1—Signaling by GPCR—CCL5—atopic dermatitis	5.73e-05	0.000413	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CCR5—atopic dermatitis	5.68e-05	0.00041	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	5.67e-05	0.000409	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—KIF3A—atopic dermatitis	5.64e-05	0.000407	CbGpPWpGaD
Irbesartan—JUN—Immune System—CASP1—atopic dermatitis	5.62e-05	0.000406	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GLB1—atopic dermatitis	5.62e-05	0.000405	CbGpPWpGaD
Irbesartan—Dizziness—Prednisone—atopic dermatitis	5.57e-05	0.000206	CcSEcCtD
Irbesartan—AGTR1—Signaling Pathways—CCR3—atopic dermatitis	5.56e-05	0.000402	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—ADSL—atopic dermatitis	5.39e-05	0.000389	CbGpPWpGaD
Irbesartan—Vomiting—Prednisone—atopic dermatitis	5.36e-05	0.000198	CcSEcCtD
Irbesartan—JUN—Immune System—IL5—atopic dermatitis	5.33e-05	0.000384	CbGpPWpGaD
Irbesartan—Rash—Prednisone—atopic dermatitis	5.31e-05	0.000196	CcSEcCtD
Irbesartan—Dermatitis—Prednisone—atopic dermatitis	5.31e-05	0.000196	CcSEcCtD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—IL6—atopic dermatitis	5.29e-05	0.000382	CbGpPWpGaD
Irbesartan—Headache—Prednisone—atopic dermatitis	5.28e-05	0.000195	CcSEcCtD
Irbesartan—AGTR1—Signaling by GPCR—CCR5—atopic dermatitis	5.16e-05	0.000372	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—NFKBIA—atopic dermatitis	5.13e-05	0.00037	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCL11—atopic dermatitis	5.1e-05	0.000368	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CMA1—atopic dermatitis	5.1e-05	0.000368	CbGpPWpGaD
Irbesartan—JUN—Immune System—TLR2—atopic dermatitis	5.08e-05	0.000367	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—IL6—atopic dermatitis	5.08e-05	0.000367	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CXCL10—atopic dermatitis	5.01e-05	0.000362	CbGpPWpGaD
Irbesartan—Nausea—Prednisone—atopic dermatitis	5.01e-05	0.000185	CcSEcCtD
Irbesartan—AGTR1—Signaling Pathways—NPS—atopic dermatitis	4.96e-05	0.000358	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TAC1—atopic dermatitis	4.96e-05	0.000358	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CXCR3—atopic dermatitis	4.86e-05	0.000351	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—STAT6—atopic dermatitis	4.79e-05	0.000346	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD79A—atopic dermatitis	4.78e-05	0.000345	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—IL6—atopic dermatitis	4.78e-05	0.000345	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CASP8—atopic dermatitis	4.63e-05	0.000334	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL5—atopic dermatitis	4.61e-05	0.000333	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—CXCL8—atopic dermatitis	4.38e-05	0.000316	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CCL5—atopic dermatitis	4.31e-05	0.000311	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—IL2—atopic dermatitis	4.18e-05	0.000302	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCR3—atopic dermatitis	4.16e-05	0.0003	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	4.09e-05	0.000295	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—NGF—atopic dermatitis	3.99e-05	0.000288	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CXCL8—atopic dermatitis	3.98e-05	0.000287	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CXCL10—atopic dermatitis	3.93e-05	0.000284	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL18—atopic dermatitis	3.91e-05	0.000282	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CCR5—atopic dermatitis	3.89e-05	0.00028	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD8A—atopic dermatitis	3.85e-05	0.000278	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—IL6—atopic dermatitis	3.84e-05	0.000277	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—IL2—atopic dermatitis	3.8e-05	0.000274	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CD4—atopic dermatitis	3.8e-05	0.000274	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TAC1—atopic dermatitis	3.71e-05	0.000267	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NPS—atopic dermatitis	3.71e-05	0.000267	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CXCR3—atopic dermatitis	3.63e-05	0.000262	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GLB1—atopic dermatitis	3.63e-05	0.000262	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—ADSL—atopic dermatitis	3.48e-05	0.000251	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL5—atopic dermatitis	3.44e-05	0.000249	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CXCL8—atopic dermatitis	3.44e-05	0.000248	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CCL5—atopic dermatitis	3.38e-05	0.000244	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—NFKBIA—atopic dermatitis	3.29e-05	0.000238	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—IL2—atopic dermatitis	3.28e-05	0.000237	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PPARA—atopic dermatitis	3.24e-05	0.000234	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—MAPK8—atopic dermatitis	3.22e-05	0.000232	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NGF—atopic dermatitis	3.13e-05	0.000226	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CXCL8—atopic dermatitis	3.12e-05	0.000225	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CCR5—atopic dermatitis	3.05e-05	0.00022	CbGpPWpGaD
Irbesartan—JUN—Immune System—NFKBIA—atopic dermatitis	2.99e-05	0.000216	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL2—atopic dermatitis	2.98e-05	0.000215	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GLB1—atopic dermatitis	2.98e-05	0.000215	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GLB1—atopic dermatitis	2.95e-05	0.000213	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CXCL10—atopic dermatitis	2.94e-05	0.000212	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—ADSL—atopic dermatitis	2.86e-05	0.000206	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—ADSL—atopic dermatitis	2.83e-05	0.000204	CbGpPWpGaD
Irbesartan—JUN—Immune System—CASP8—atopic dermatitis	2.69e-05	0.000194	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.64e-05	0.000191	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—NFKBIA—atopic dermatitis	2.58e-05	0.000187	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCL5—atopic dermatitis	2.53e-05	0.000182	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GLB1—atopic dermatitis	2.52e-05	0.000182	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—ADSL—atopic dermatitis	2.42e-05	0.000175	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CXCL8—atopic dermatitis	2.35e-05	0.00017	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NGF—atopic dermatitis	2.34e-05	0.000169	CbGpPWpGaD
Irbesartan—JUN—Immune System—IFNG—atopic dermatitis	2.29e-05	0.000165	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CCR5—atopic dermatitis	2.28e-05	0.000164	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL2—atopic dermatitis	2.24e-05	0.000162	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—IL6—atopic dermatitis	2.23e-05	0.000161	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD4—atopic dermatitis	2.21e-05	0.00016	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.15e-05	0.000155	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MAPK8—atopic dermatitis	2.07e-05	0.000149	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—IL6—atopic dermatitis	2.05e-05	0.000148	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL1B—atopic dermatitis	2.04e-05	0.000147	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL2—atopic dermatitis	2.04e-05	0.000147	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GLB1—atopic dermatitis	1.95e-05	0.000141	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—NFKBIA—atopic dermatitis	1.93e-05	0.000139	CbGpPWpGaD
Irbesartan—JUN—Immune System—MAPK8—atopic dermatitis	1.87e-05	0.000135	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—ADSL—atopic dermatitis	1.87e-05	0.000135	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CXCL8—atopic dermatitis	1.84e-05	0.000133	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.84e-05	0.000133	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PPARA—atopic dermatitis	1.82e-05	0.000132	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL2—atopic dermatitis	1.76e-05	0.000127	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL6—atopic dermatitis	1.75e-05	0.000126	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MAPK8—atopic dermatitis	1.62e-05	0.000117	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CXCL8—atopic dermatitis	1.38e-05	9.94e-05	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL6—atopic dermatitis	1.32e-05	9.52e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL2—atopic dermatitis	1.32e-05	9.5e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MAPK8—atopic dermatitis	1.21e-05	8.74e-05	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL6—atopic dermatitis	1.2e-05	8.63e-05	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PPARA—atopic dermatitis	1.18e-05	8.5e-05	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL6—atopic dermatitis	1.04e-05	7.47e-05	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PPARA—atopic dermatitis	9.67e-06	6.98e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PPARA—atopic dermatitis	9.58e-06	6.92e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PPARA—atopic dermatitis	8.19e-06	5.91e-05	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL6—atopic dermatitis	7.74e-06	5.58e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PPARA—atopic dermatitis	6.32e-06	4.56e-05	CbGpPWpGaD
